Inventor

SULEA TRAIAN

CA34 patents

⚠️ This page may combine multiple inventors who share the name “SULEA TRAIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SULEA TRAIAN

NAT RES COUNCIL CANADA

Antagonists of ligands and uses thereof

Humanized antibodies transmigrating the blood-brain barrier and uses thereof

Antibody variants transmigrating the blood-brain barrier and uses thereof

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

TGF-β-receptor ectodomain fusion molecules and uses thereof

TGF-β-receptor ectodomain fusion molecules and uses thereof

Antibody glycoconjugates and methods of production and use

Antibody variants with pH-dependent antigen binding for selective targeting of solid tumors

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

Serum albumin binding antibodies for tuneable half-life extension of biologics

Anti-EGFRvIII antibodies and antigen-binding fragments thereof

Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications

Antigen-binding agents that specifically bind epidermal growth factor receptor variant III

ALETHIA BIOTHERAPEUTICS INC

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Anti-Siglec-15 antibodies

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

TREMBLAY GILLES BERNARD

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

Anti-kidney associated antigen 1 (KAAG1) antibodies

O'CONNOR-MCCOURT MAUREEN D

Antagonists of ligands and uses thereof

Antagonist of ligands and uses thereof

ADC THERAPEUTICS SA

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

Antibodies against kidney associated antigen 1 and antigen binding fragments thereof

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

Engineered TGF-β monomers and their use for inhibiting TGF-β signaling

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling

TIKHOMIROV ILIA ALEXANDRE

Antibodies selective for cells presenting ErbB2 at high density

Antibodies selective for cells presenting EGFR at high density

ZWAAGSTRA JOHN C

Covalently dimerized bivalent binding agents

CA NAT RESEARCH COUNCIL

Antagonists of ligands and uses thereof

GILEAD SCIENCES INC

Antibodies selective for cells presenting EGFR at high density

UNIV LAVAL

Humanized anti-S100A9 antibody and uses thereof

ME THERAPEUTICS INC

Anti-G-CSF antibodies and uses thereof

THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV

Soluble IGF receptor Fc fusion proteins and uses thereof